Autoplaque vs Affiniti Series Diagnostic Ultrasound Systems

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Autoplaque
by APQ Health (formerly Cedars-Sinai Medical Center: AIM)
VS
Affiniti Series Diagnostic Ultrasound Systems
by Philips Ultrasound

AI Verdict

Autoplaque is an AI-powered software for analyzing existing CT angiography images to quantify coronary plaque and stenosis, aiding in heart attack risk prediction. The Philips Affiniti Series Diagnostic Ultrasound Systems are hardware ultrasound machines that acquire real-time diagnostic images for various clinical needs, including cardiology, with some AI-powered features for image optimization and workflow. While both are FDA-cleared and used in cardiology, Autoplaque is a post-processing software for CT images, whereas Affiniti is an ultrasound imaging system.

Choose Autoplaque if…

Choose Autoplaque if your primary need is AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This workstation-based software is ideal for cardiologists and radiologists seeking to precisely assess heart attack risk and guide treatment plans through detailed characterization of coronary artery pathology.

View Autoplaque →

Choose Affiniti Series Diagnostic Ultrasound Systems if…

Choose Philips Affiniti Series Diagnostic Ultrasound Systems if you require a versatile, on-premise ultrasound solution for a wide range of clinical needs, including cardiology, OB/GYN, and general radiology. Its advanced imaging features, such as PureWave technology and Anatomical Intelligence, are well-suited for diagnostic confidence and efficient workflows in everyday ultrasound examinations.

View Affiniti Series Diagnostic Ultrasound Systems →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Autoplaque Affiniti Series Diagnostic Ultrasound Systems
Pricing Unknown Varies by model and condition (new/refurbished). generally considered a 'mid tier' or 'budget' shared service ultrasound with rich image quality at an affordable price point compared to premium models.
Deployment Workstation-based post-processing application, runs on Windows or Mac OS. On-premise (console hardware system)
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Affiniti Series Diagnostic Ultrasound Systems

Philips Affiniti Series Diagnostic Ultrasound Systems emphasize 'walk-up usability,' intuitive interfaces, and ergonomic design to reduce user strain and training time. Studies have validated that users with ultrasound experience require minimal training. Autoplaque is workstation-based software, and while it offers automated segmentation, there is less explicit information about its overall user experience and ergonomic considerations.

Clinical Value

Affiniti Series Diagnostic Ultrasound Systems

Both tools offer significant clinical value. Autoplaque provides AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography, aiding in heart attack risk prediction and treatment guidance. Philips Affiniti Series, however, offers a broader range of advanced imaging for diverse clinical needs, including cardiology, OB/GYN, and radiology, with features like PureWave technology and Anatomical Intelligence, contributing to diagnostic confidence and reproducibility across multiple specialties.

Pricing & Value

Affiniti Series Diagnostic Ultrasound Systems

Philips Affiniti Series Diagnostic Ultrasound Systems have publicly available pricing information, with various models and conditions (new/refurbished) ranging from approximately $12,990 to over $77,226. This transparency allows for a clearer assessment of value. Autoplaque's pricing is not disclosed, making it difficult to evaluate its value proposition in comparison.

Enterprise Readiness

Affiniti Series Diagnostic Ultrasound Systems

Philips Affiniti Series Diagnostic Ultrasound Systems are designed for enterprise use, with features like DICOM and PC format capabilities for information sharing, structured reporting, and wireless connectivity. They also offer remote services monitoring and a modular design for enhanced reliability and rapid repair, indicating robust enterprise support. Autoplaque is workstation-based software, and while it is FDA-cleared and HIPAA compliant (implied by its use in clinical studies), there is less information regarding its broader enterprise deployment and management features beyond basic system requirements.

Innovation

Affiniti Series Diagnostic Ultrasound Systems

Both tools demonstrate innovation in their respective fields. Autoplaque utilizes deep learning for automated vessel, plaque, and lumen segmentation, offering advanced quantitative analysis of atherosclerotic plaque. However, Philips Affiniti Series incorporates a wider array of innovative technologies such as PureWave crystal technology, Anatomical Intelligence Ultrasound (AIUS), xMatrix transducer technology, and NextGen Auto Scan for adaptive image optimization across diverse clinical applications.

Support & Docs

Affiniti Series Diagnostic Ultrasound Systems

Philips offers comprehensive support and documentation for its Affiniti series, including user manuals, DICOM conformance statements, and access to an award-winning service organization, remote services, and educational programs. Autoplaque's documentation mentions a user manual with minimum hardware specifications, but detailed information about ongoing support services is not readily available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Autoplaque Affiniti Series Diagnostic Ultrasound Systems
Name Autoplaque Affiniti Series Diagnostic Ultrasound Systems
Company Cedars-Sinai Medical Center: AIM Philips Ultrasound
Description Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. The Philips Affiniti Series Diagnostic Ultrasound Systems offer advanced imaging for diverse clinical needs, featuring PureWave technology, Anatomical Intelligence, and efficient workflows for confident diagnosis.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, OB/GYN AI, Radiology & Imaging AI
Key Features AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area PureWave crystal technology; Tissue Specific Presets (TSPs); Anatomical Intelligence Ultrasound (AIUS); xMatrix transducer technology (for versatile data acquisition); NextGen Auto Scan (adaptive image optimization); TrueVue and FlexVue (photorealistic OB/GYN imaging); Flow Viewer and MicroFlow Imaging (MFI); ShearWave and Strain elastography

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and Affiniti Series Diagnostic Ultrasound Systems.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Autoplaque is a workstation-based post-processing application that analyzes CT angiography images to quantify coronary plaques and luminal stenoses, aiding in heart attack risk prediction and treatment guidance. The Philips Affiniti Series, on the other hand, is a console-based ultrasound system that provides real-time diagnostic imaging for a variety of clinical needs, including cardiology, with features like Tissue Specific Presets and Anatomical Intelligence to streamline the ultrasound exam workflow.
Autoplaque, as a software application, involves learning its interface for reviewing and editing automated segmentations of vessels, plaques, and lumens. The Philips Affiniti Series, being a comprehensive ultrasound system, would require familiarization with its console, transducers, and various imaging modes and features like PureWave technology and Anatomical Intelligence Ultrasound (AIUS) for optimal use.
For Autoplaque, developed by Cedars-Sinai AIM, support would likely come from their development team, potentially including updates and technical assistance for the workstation-based software. Philips, as a large medical device company, typically offers comprehensive support, including training, technical service, and potentially clinical applications support for their Affiniti Series ultrasound systems.
Autoplaque's automated vessel, plaque, and lumen segmentation, which is reviewable and editable by clinicians, would likely generate a record of the analysis performed on CT angiography images. The Philips Affiniti Series, as a diagnostic ultrasound system, would produce imaging studies that are typically stored within the facility's picture archiving and communication system (PACS), contributing to the patient's overall diagnostic record.
While specific details beyond HIPAA compliance are not provided for Autoplaque, its workstation-based nature would rely on the security posture of the individual computer and network it operates within. The Philips Affiniti Series, as an on-premise hardware system, would have its own internal security protocols for data handling and storage, in addition to the security measures of the hospital's network infrastructure.
For Autoplaque, being developed by Cedars-Sinai AIM, there might be opportunities to connect with the Cedars-Sinai network or through academic cardiology and radiology communities. Philips, with its widespread adoption of ultrasound systems like the Affiniti Series, likely has a broad user base and potentially user groups or forums for sharing insights and best practices among clinicians.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Autoplaque or Affiniti Series Diagnostic Ultrasound Systems

AI Tool Finder
AI-powered search. Results may not be comprehensive.